Literature DB >> 17020402

Brimonidine/Timolol: a viewpoint by Francisco J. Goñi.

Francisco J Goñi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17020402     DOI: 10.2165/00002512-200623090-00006

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


× No keyword cloud information.
  1 in total

1.  Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.

Authors:  Mark B Sherwood; E Randy Craven; Connie Chou; Harvey B DuBiner; Amy L Batoosingh; Rhett M Schiffman; Scott M Whitcup
Journal:  Arch Ophthalmol       Date:  2006-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.